Previously treated cases tested for RR-/MDR-TB (%) in Morocco
Morocco: Previously treated cases tested for RR-/MDR-TB was 55.0% in 2024. ◆ Volatile
Previously treated cases tested for RR-/MDR-TB in Morocco, 2008–2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, previously treated cases tested for rr-/mdr-tb in Morocco stood at 55.0%.
That represents a change of down 6.8% on the previous year and up 292.9% over ten years.
Over the whole period, previously treated cases tested for rr-/mdr-tb in Morocco peaked at 100.0% in 2019 and was at its lowest, 9.8%, in 2011.
That places Morocco 145th out of 180 countries with data for 2024, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Previously treated cases tested for RR-/MDR-TB in Morocco, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 19.0% | — |
| 2010 | 24.0% | +26.3% |
| 2011 | 9.8% | -59.2% |
| 2012 | 21.0% | +114.3% |
| 2013 | 14.0% | -33.3% |
| 2014 | 14.0% | +0.0% |
| 2015 | 15.0% | +7.1% |
| 2016 | 71.0% | +373.3% |
| 2017 | 56.0% | -21.1% |
| 2018 | 99.0% | +76.8% |
| 2019 | 100.0% | +1.0% |
| 2021 | 100.0% | +0.0% |
| 2022 | 100.0% | +0.0% |
| 2023 | 59.0% | -41.0% |
| 2024 | 55.0% | -6.8% |
Morocco compared with similar countries
- Morocco's 55.0% is below the median for lower middle income countries, which is 90.0%, 61% of the median. (47 countries reporting)
- Morocco's 55.0% is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 90.5%, 61% of the median. (20 countries reporting)
Biggest year-on-year movements
Years where Previously treated cases tested for RR-/MDR-TB in Morocco changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2016 | +373.3% | 15.0% | 71.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 19.0% | 19.0% | 19.0% | 1 |
| 2010s | 42.4% | 9.8% | 100.0% | 10 |
| 2020s | 78.5% | 55.0% | 100.0% | 4 |
Countries ranked near Morocco
More health data for Morocco
- Un projection of annual infant deaths, annual growth rate -1.91 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6655 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,240 deaths per 1,000 people (2090)
- Number of infants who die before age 1 925 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 3 (2018)
- Population ages 00-04, female, annual growth rate -1.13 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0396 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.1 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is previously treated cases tested for rr-/mdr-tb in Morocco?
- Previously treated cases tested for rr-/mdr-tb in Morocco was 55.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest previously treated cases tested for rr-/mdr-tb recorded in Morocco?
- The highest recorded value was 100.0% in 2019.
- What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Morocco?
- The lowest recorded value was 9.8% in 2011.
- How does Morocco rank for previously treated cases tested for rr-/mdr-tb?
- Morocco ranks 145th out of 180 countries with data for 2024.
- Is previously treated cases tested for rr-/mdr-tb rising or falling in Morocco?
- Over the last ten years it is up 292.9%. The long-run trend across the full record is volatile.
- Where does this Morocco data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 15 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).